BioNTech SE (BNTX)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in BioNTech SE in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $91,220 for a total return of roughly 812.20%. All prices are adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: BNTX vs. MRNA, BNTX vs. VTI
Return
BioNTech SE had a return of -14.66% year-to-date (YTD) and -21.90% in the last 12 months. Over the past 10 years, BioNTech SE had an annualized return of 89.85%, outperforming the S&P 500 benchmark which had an annualized return of 9.13%.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -6.78% | -0.66% |
| Year-To-Date | -14.66% | 3.42% |
| 6 months | -1.38% | 5.67% |
| 1 year | -21.90% | -10.89% |
| 5 years (annualized) | 89.85% | 9.13% |
| 10 years (annualized) | 89.85% | 9.13% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -4.53% | -9.32% | ||||||||||
| 2022 | -6.75% | 2.05% | 21.35% | -10.06% |
Dividend History
BioNTech SE granted a 1.65% dividend yield in the last twelve months. The annual payout for that period amounted to $2.11 per share.
| Period | TTM | 2022 |
|---|---|---|
| Dividend | $2.11 | $2.11 |
Dividend yield | 1.65% | 1.41% |
Monthly Dividends
The table displays the monthly dividend distributions for BioNTech SE. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | $0.00 | $0.00 | ||||||||||
| 2022 | $2.11 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the BioNTech SE. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the BioNTech SE is 73.17%, recorded on Oct 20, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -73.17% | Aug 10, 2021 | 303 | Oct 20, 2022 | — | — | — |
| -58.07% | Mar 19, 2020 | 19 | Apr 15, 2020 | 68 | Jul 22, 2020 | 87 |
| -44.5% | Jul 23, 2020 | 29 | Sep 1, 2020 | 48 | Nov 9, 2020 | 77 |
| -37.07% | Dec 11, 2020 | 14 | Dec 31, 2020 | 69 | Apr 13, 2021 | 83 |
| -36.7% | Jan 9, 2020 | 44 | Mar 12, 2020 | 3 | Mar 17, 2020 | 47 |
| -22.91% | Nov 11, 2020 | 5 | Nov 17, 2020 | 8 | Nov 30, 2020 | 13 |
| -20.51% | Dec 18, 2019 | 2 | Dec 19, 2019 | 8 | Jan 2, 2020 | 10 |
| -20.25% | Oct 23, 2019 | 4 | Oct 28, 2019 | 19 | Nov 22, 2019 | 23 |
| -19.58% | May 4, 2021 | 3 | May 6, 2021 | 18 | Jun 2, 2021 | 21 |
| -15.59% | Jun 10, 2021 | 5 | Jun 16, 2021 | 22 | Jul 19, 2021 | 27 |
Volatility Chart
Current BioNTech SE volatility is 26.10%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.